Menlo Park, US-based biotechnology company developing biopharmaceuticals and genetic engineering tools for healthcare and agriculture.
Refuge Biotechnologies develops biopharmaceuticals and genetic engineering tools for healthcare and agricultural needs, serving healthcare providers, farmers and research institutions. Founded in 2015 and headquartered in Menlo Park, US, the company raised USD 25.00 mn in its most recent Series B round, with investors including 3E Bioventures Capital and Sequoia Capital. CEO Bing Wang leads the company, which has completed two deals, and David Parkinson is listed as a founder.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in